 |
Clinical Image
Central retinal vein occlusion following mRNA severe acute respiratory syndrome coronavirus 2 vaccination
1 Department of Ophthalmology, Jichi Medical University, Shimotsuke, Tochigi, Japan
Address correspondence to:
Kumiko Noguchi
Department of Ophthalmology, Jichi Medical University, Shimotsuke, Tochigi,
Japan
Message to Corresponding Author
Article ID: 101337Z01KN2022
Access full text article on other devices
Access PDF of article on other devices
How to cite this article
Noguchi K, Takahashi R, Makino S. Central retinal vein occlusion following mRNA severe acute respiratory syndrome coronavirus 2 vaccination. Int J Case Rep Images 2022;13(2):105–107.ABSTRACT
No Abstract
Keywords: Central retinal vein occlusion, Coronavirus disease 2019 (COVID-19) vaccination, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
SUPPORTING INFORMATION
Author Contributions
Kumiko Noguchi - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Ryota Takahashi - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Shinji Makino - Substantial contributions to conception and design, Analysis of data, Interpretation of data, Drafting the article, Final approval of the version to be published
Guarantor of SubmissionThe corresponding author is the guarantor of submission.
Source of SupportNone
Consent StatementWritten informed consent was obtained from the patient for publication of this article.
Data AvailabilityAll relevant data are within the paper and its Supporting Information files.
Conflict of InterestAuthors declare no conflict of interest.
Copyright© 2022 Kumiko Noguchi et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.
